Showing results (71-80 of 775) with videos related to

Sort By:
Pageof 78
Virusdisease|February 13, 2015
Epidemiology of human and animal kobuvirusesPattara Khamrin, Niwat Maneekarn, Shoko Okitsu, et al.
The Journal of Organic Chemistry|December 12, 2025
Domino Dearomative Iodocyclization/Intramolecular Diels-Alder Reaction for Rapid Construction of Polycyclic ScaffoldsTakashi Okitsu, Hikaru Saito, Kiyoshi Tsuge, et al.
Kyobu Geka. the Japanese Journal of Thoracic Surgery|July 1, 1989
[Endoscopic Nd-YAG laser treatment in lung cancer]K Oho, R Amemiya, H Okitsu, et al.
Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry|January 8, 2005
Mechanism of the NO2 conversion to NO2- in an alkaline solutionXinyu Chen, Kenji Okitsu, Norimichi Takenaka, et al.
Acta Crystallographica. Section A, Foundations of Crystallography|February 8, 2002
X-ray four-quadrant diamond phase-retarder system to compensate for off-axis and chromatic aberrationsKouhei Okitsu, Yoshinori Ueji, Kiminori Sato, et al.
Chemosphere|May 20, 2009
Sonochemical decomposition of hydrazine in water: effects of coal ash and pH on the decomposition and adsorption behaviorHiroyuki Nakui, Kenji Okitsu, Yasuaki Maeda, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2003
A simple stereoselective synthesis and biological evaluation of FR181157: orally active prostacyclin mimeticKouji Hattori, Seiichiro Tabuchi, Osamu Okitsu, et al.
Acta Crystallographica. Section A, Foundations of Crystallography|July 2, 2003
'Six-beam X-ray section topograph' images and computer-simulated images using the new n-beam dynamical theory based on the Takagi-Taupin equationsKouhei Okitsu, Yasuhiko Imai, Yoshinori Ueji, et al.
Journal of Medical Virology|March 22, 2005
Determination of HIV-1 subtypes (A-D, F, G, CRF01_AE) by PCR in the transmembrane region (gp41) with novel primersFumihiro Yagyu, Shoko Okitsu, Kenichi Tanamoto, et al.
Eneurologicalsci|June 9, 2025
Effects of immunotherapy on isolated optic neuritis associated with ozoralizumab, a novel anti-tumor necrosis factor α NANOBODY® compound: A case reportMasato Okitsu, Keizo Sugaya, Yuya Shiotani, et al.
Pageof 78